# GLYAT

## Overview
The GLYAT gene encodes the enzyme glycine-N-acyltransferase, a mitochondrial enzyme predominantly expressed in the liver and kidney. This enzyme is a member of the GNAT (Gcn5-related N-acetyltransferase) superfamily, characterized by its conserved GNAT fold, which is integral to its catalytic function. Glycine-N-acyltransferase plays a pivotal role in detoxification processes by catalyzing the conjugation of acyl-CoA substrates with glycine, resulting in the formation of acylglycines that are more hydrophilic and readily excreted in urine. This enzymatic activity is crucial for maintaining metabolic homeostasis and preventing the accumulation of potentially toxic acyl-CoA compounds. The GLYAT gene's expression and function have significant implications for metabolic health and disease, including its potential role as a biomarker in hepatocellular carcinoma and its involvement in musculoskeletal development (Ebrecht2021Structure; Matsuo2012Designation; Badenhorst2013Glycine).

## Structure
The human glycine-N-acyltransferase (GLYAT) protein is encoded by a gene that produces a polypeptide consisting of 295 amino acids (Matsuo2012Designation). The enzyme is specifically expressed in the liver and kidney, with its cellular localization restricted to the mitochondria (Matsuo2012Designation). The structure of GLYAT includes a conserved GNAT fold, which is a characteristic feature of the enzyme's catalytic domain (Ebrecht2021Structure). This domain is involved in the enzyme's function of conjugating acyl groups to glycine, a key step in detoxification processes (Ebrecht2021Structure).

The catalytic mechanism of GLYAT involves a catalytic dyad, Glu226-His263, which facilitates the nucleophilic attack by the amino group of glycine on the thioester carbonyl group of acyl-CoA (Ebrecht2021Structure). The enzyme's structure also includes a V-shaped cleft that accommodates benzoyl-CoA, with the acyl donor adopting a C-shaped orientation (Ebrecht2021Structure). Post-translational modifications such as acetylation and phosphorylation are suggested to occur, potentially influencing the enzyme's activity and stability (Ebrecht2021Structure). The enzyme is highly conserved among mammals, indicating its essential role in metabolism (Ebrecht2021Structure).

## Function
The GLYAT gene encodes the enzyme glycine N-acyltransferase, which plays a crucial role in detoxification processes within the mitochondria of liver and kidney cells. This enzyme catalyzes the conjugation of acyl-CoA substrates with glycine, forming acylglycines that are more hydrophilic and can be excreted in urine. This process is essential for maintaining metabolic homeostasis by preventing the accumulation of potentially harmful acyl-CoA compounds (Matsuo2012Designation; Badenhorst2013Glycine).

GLYAT is involved in the detoxification of various xenobiotic and endogenous metabolites, including benzoate and salicylate, by converting them into less toxic forms. This activity is significant for the metabolism of dietary polyphenols and other compounds, ensuring their safe excretion and preventing the depletion of coenzyme A (CoASH) reserves, which are vital for metabolic functions like β-oxidation and lipogenesis (van2015Conservation; Badenhorst2013Glycine).

The enzyme is predominantly expressed in the liver and kidney, where it localizes to the mitochondrial matrix. Its activity is crucial for nitrogen metabolism and has therapeutic implications, such as in sodium benzoate therapy for congenital hyperammonemias (Matsuo2012Designation).

## Clinical Significance
The GLYAT gene is clinically significant due to its role in detoxification processes and its association with various diseases. Alterations in GLYAT expression have been linked to hepatocellular carcinoma (HCC), a type of liver cancer. In HCC, GLYAT expression is significantly downregulated, which may be a strategy to conserve glycine for nucleic acid synthesis, supporting the rapid proliferation of cancer cells (Matsuo2012Designation; Badenhorst2013Glycine). This downregulation suggests that GLYAT could serve as a potential marker for HCC diagnosis and prognosis (Matsuo2012Designation).

Variations in the GLYAT gene can also impact musculoskeletal development. Single nucleotide polymorphisms (SNPs) in and near the GLYAT gene have been correlated with variations in lean muscle mass and bone size, possibly due to the enzyme's influence on glycine availability, which is crucial for collagen turnover and musculoskeletal growth (Badenhorst2013Glycine; Badenhorst2014A).

Furthermore, GLYAT activity is involved in the metabolism of xenobiotics and organic acids. Impaired GLYAT function can lead to adverse drug reactions and may play a role in complex diseases like cancer, as it affects the detoxification of harmful compounds (van2013Characterisation; Badenhorst2013Glycine).


## References


1. (Ebrecht2021Structure) Structure of glycine N-acyltransferase clarifies its catalytic mechanism. This article has 0 citations.

[2. (Matsuo2012Designation) Moe Matsuo, Kensuke Terai, Noriaki Kameda, Aya Matsumoto, Yumiko Kurokawa, Yuichi Funase, Kazuko Nishikawa, Naoki Sugaya, Nobuyuki Hiruta, and Toshihiko Kishimoto. Designation of enzyme activity of glycine-n-acyltransferase family genes and depression of glycine-n-acyltransferase in human hepatocellular carcinoma. Biochemical and Biophysical Research Communications, 420(4):901–906, April 2012. URL: http://dx.doi.org/10.1016/j.bbrc.2012.03.099, doi:10.1016/j.bbrc.2012.03.099. This article has 34 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2012.03.099)

[3. (van2015Conservation) Rencia van der Sluis, Christoffel P.S. Badenhorst, Elardus Erasmus, Etresia van Dyk, Francois H. van der Westhuizen, and Alberdina A. van Dijk. Conservation of the coding regions of the glycine n-acyltransferase gene further suggests that glycine conjugation is an essential detoxification pathway. Gene, 571(1):126–134, October 2015. URL: http://dx.doi.org/10.1016/j.gene.2015.06.081, doi:10.1016/j.gene.2015.06.081. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.gene.2015.06.081)

[4. (van2013Characterisation) Rencia van der Sluis, Christoffel P.S. Badenhorst, Francois H. van der Westhuizen, and Alberdina A. van Dijk. Characterisation of the influence of genetic variations on the enzyme activity of a recombinant human glycine n-acyltransferase. Gene, 515(2):447–453, February 2013. URL: http://dx.doi.org/10.1016/j.gene.2012.12.003, doi:10.1016/j.gene.2012.12.003. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.gene.2012.12.003)

[5. (Badenhorst2014A) Christoffel Petrus Stephanus Badenhorst, Elardus Erasmus, Rencia van der Sluis, Carla Nortje, and Alberdina Aike van Dijk. A new perspective on the importance of glycine conjugation in the metabolism of aromatic acids. Drug Metabolism Reviews, 46(3):343–361, April 2014. URL: http://dx.doi.org/10.3109/03602532.2014.908903, doi:10.3109/03602532.2014.908903. This article has 59 citations and is from a peer-reviewed journal.](https://doi.org/10.3109/03602532.2014.908903)

[6. (Badenhorst2013Glycine) Christoffel Petrus Stephanus Badenhorst, Rencia van der Sluis, Elardus Erasmus, and Alberdina Aike van Dijk. Glycine conjugation: importance in metabolism, the role of glycinen-acyltransferase, and factors that influence interindividual variation. Expert Opinion on Drug Metabolism &amp; Toxicology, 9(9):1139–1153, May 2013. URL: http://dx.doi.org/10.1517/17425255.2013.796929, doi:10.1517/17425255.2013.796929. This article has 56 citations.](https://doi.org/10.1517/17425255.2013.796929)